tooluniverse-disease-research

0
0
Source

Generate comprehensive disease research reports using 100+ ToolUniverse tools. Creates a detailed markdown report file and progressively updates it with findings from 10 research dimensions. All information includes source references. Use when users ask about diseases, syndromes, or need systematic disease analysis.

Install

mkdir -p .claude/skills/tooluniverse-disease-research && curl -L -o skill.zip "https://mcp.directory/api/skills/download/9380" && unzip -o skill.zip -d .claude/skills/tooluniverse-disease-research && rm skill.zip

Installs to .claude/skills/tooluniverse-disease-research

About this skill

ToolUniverse Disease Research

Generate a comprehensive disease research report with full source citations. The report is created as a markdown file and progressively updated during research.

IMPORTANT: Always use English disease names and search terms in tool calls. Respond in the user's language.


LOOK UP, DON'T GUESS

When asked about a disease, query Orphanet/OMIM/DisGeNET FIRST. Don't rely on memory for prevalence, genetics, or treatment — these change over time. When you're not sure about a fact, your first instinct should be to SEARCH for it using tools, not to reason harder from memory.


When to Use

  • User asks about any disease, syndrome, or medical condition
  • Needs comprehensive disease intelligence or a detailed research report
  • Asks "what do we know about [disease]?"

Core Workflow: Report-First Approach

DO NOT show the search process to the user. Instead:

  1. Create report file first - Initialize {disease_name}_research_report.md
  2. Research each dimension - Use all relevant tools
  3. Update report progressively - Write findings after each dimension
  4. Include citations - Every fact must reference its source tool

Disease Mechanism Reasoning

When synthesizing disease etiology, trace the full pathogenic cascade:

  1. Genetic basis - Which variants (rare or common) confer risk, and in which genes?
  2. Molecular mechanism - How do those variants alter protein function, expression, or regulation?
  3. Cellular effect - What downstream cellular processes are disrupted (signaling, metabolism, stress response)?
  4. Tissue/organ manifestation - How does cellular dysfunction present as organ-level pathology?

This chain structures the Genetic & Molecular Basis (Section 3) and Biological Pathways (Section 5) sections.


10 Research Dimensions

DimSectionKey Tools
1Identity & ClassificationOSL_get_efo_id_by_disease_name, ols_search_efo_terms, ols_get_efo_term, umls_search_concepts, icd_search_codes, snomed_search_concepts
2Clinical PresentationOpenTargets phenotypes, HPO lookup, MedlinePlus
3Genetic & Molecular BasisOpenTargets targets, ClinVar variants, GWAS associations, gnomAD
4Treatment LandscapeOpenTargets drugs, clinical trials, GtoPdb
5Biological PathwaysReactome pathways, humanbase_ppi_analysis, GTEx expression, HPA
6Epidemiology & LiteraturePubMed, OpenAlex, Europe PMC, Semantic Scholar
7Similar DiseasesOpenTargets similar entities
8Cancer-Specific (if applicable)CIViC genes/variants/therapies
9PharmacologyGtoPdb targets/interactions/ligands
10Drug SafetyOpenTargets warnings, clinical trial AEs, FAERS

See: tool_usage_details.md for complete tool calls per section.


Report Template

Create this file structure at the start:

# Disease Research Report: {Disease Name}

**Report Generated**: {date}
**Disease Identifiers**: (to be filled)

---

## Executive Summary
(Brief 3-5 sentence overview - fill after all research complete)

---

## 1. Disease Identity & Classification
### Ontology Identifiers
| System | ID | Source |

### Synonyms & Alternative Names
### Disease Hierarchy

---

## 2. Clinical Presentation
### Phenotypes (HPO)
| HPO ID | Phenotype | Description | Source |

### Symptoms & Signs
### Diagnostic Criteria

---

## 3. Genetic & Molecular Basis
### Associated Genes
| Gene | Score | Ensembl ID | Evidence | Source |

### GWAS Associations
| SNP | P-value | Odds Ratio | Study | Source |

### Pathogenic Variants (ClinVar)

---

## 4. Treatment Landscape
### Approved Drugs
| Drug | ChEMBL ID | Mechanism | Phase | Target | Source |

### Clinical Trials
| NCT ID | Title | Phase | Status | Source |

---

## 5. Biological Pathways & Mechanisms

## 6. Epidemiology & Risk Factors

## 7. Literature & Research Activity

## 8. Similar Diseases & Comorbidities

## 9. Cancer-Specific Information (if applicable)

## 10. Drug Safety & Adverse Events

---

## References
### Tools Used
| # | Tool | Parameters | Section | Items Retrieved |

Citation Format

Every piece of data MUST include its source:

In tables: Add a Source column with tool name In lists: - Finding [Source: tool_name] In prose: (Source: tool_name, query: "...") References section: Complete tool usage log with parameters


Progressive Update Pattern

# After each dimension's research:
# 1. Read current report
# 2. Replace placeholder with formatted content
# 3. Write back immediately
# 4. Continue to next dimension

Evidence Grading & Interpretation

Every finding in the report should be graded:

GradeCriteriaExample
T1 (Strong)Replicated genetic evidence (GWAS, rare variants), FDA-approved therapyBRCA1 → breast cancer; trastuzumab for HER2+
T2 (Moderate)Single genetic study, phase II+ trial data, strong biological evidenceFOXO3 → longevity (centenarian studies)
T3 (Association)Observational data, gene expression changes, pathway membershipIL-6 elevated in Alzheimer's CSF
T4 (Computational)Network proximity, text mining, predicted associationsDisGeNET text-mined gene-disease link

Synthesis Questions (answer in Executive Summary)

After collecting data from all 10 dimensions, the report MUST answer:

  1. What causes this disease? Summarize the genetic architecture (monogenic vs polygenic, key loci, penetrance)
  2. What are the therapeutic options? Ranked by evidence level and approval status
  3. What biomarkers exist? For diagnosis, prognosis, and treatment selection
  4. What's the unmet need? What aspects lack effective treatment or understanding?
  5. What are the active research frontiers? Based on clinical trials and recent publications

Interpreting Cross-Database Concordance

When multiple databases provide different data for the same disease:

  • OpenTargets + DisGeNET + OMIM agree on a gene: T1 evidence — high confidence
  • Only OpenTargets reports an association: Check the datasource scores — genetic_association > literature > animal_model
  • DisGeNET score > 0.5 but not in OpenTargets: May be text-mined; verify with PubMed
  • Gene in GWAS but not OMIM: Likely a complex disease susceptibility locus, not Mendelian

Handling Conflicting Data

ConflictResolution
Different prevalence estimates across sourcesReport range; note the most recent/largest study
Drug approved in one country but not anotherNote regulatory status per region
Gene-disease association in one DB but absent in anotherGrade by evidence type; text-mining alone is T4
Clinical trial results contradict label indicationsThe trial result is newer evidence; note both

Final Report Quality Checklist

  • All 10 sections have content (or marked "No data available")
  • Every data point has a source citation
  • Executive summary reflects key findings
  • References section lists all tools used
  • Tables properly formatted
  • No placeholder text remains

Expected Output Scale

For a well-studied disease (e.g., Alzheimer's), the final report should include:

  • 5+ ontology IDs, 10+ synonyms, disease hierarchy
  • 20+ phenotypes with HPO IDs
  • 50+ genes, 30+ GWAS associations, 100+ ClinVar variants
  • 20+ drugs, 50+ clinical trials
  • 10+ pathways, PPI network, expression data
  • 100+ publications
  • 15+ similar diseases
  • Drug warnings and adverse events

Total: 500+ individual data points, each with source citation.


Cross-Skill References

For rare disease differential diagnosis, run: python3 skills/tooluniverse-rare-disease-diagnosis/scripts/clinical_patterns.py --type differential --symptoms 'symptom1,symptom2'


Reference Files

tooluniverse-precision-oncology

mims-harvard

Provide actionable treatment recommendations for cancer patients based on molecular profile. Interprets tumor mutations, identifies FDA-approved therapies, finds resistance mechanisms, matches clinical trials. Use when oncologist asks about treatment options for specific mutations (EGFR, KRAS, BRAF, etc.), therapy resistance, or clinical trial eligibility.

203

tooluniverse-drug-research

mims-harvard

Generates comprehensive drug research reports with compound disambiguation, evidence grading, and mandatory completeness sections. Covers identity, chemistry, pharmacology, targets, clinical trials, safety, pharmacogenomics, and ADMET properties. Use when users ask about drugs, medications, therapeutics, or need drug profiling, safety assessment, or clinical development research.

213

tooluniverse-pharmacovigilance

mims-harvard

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

192

tooluniverse-expression-data-retrieval

mims-harvard

Retrieves gene expression and omics datasets from ArrayExpress and BioStudies with gene disambiguation, experiment quality assessment, and structured reports. Creates comprehensive dataset profiles with metadata, sample information, and download links. Use when users need expression data, omics datasets, or mention ArrayExpress (E-MTAB, E-GEOD) or BioStudies (S-BSST) accessions.

172

drug-repurposing

mims-harvard

Identify drug repurposing candidates using ToolUniverse for target-based, compound-based, and disease-driven strategies. Searches existing drugs for new therapeutic indications by analyzing targets, bioactivity, safety profiles, and literature evidence. Use when exploring drug repurposing opportunities, finding new indications for approved drugs, or when users mention drug repositioning, off-label uses, or therapeutic alternatives.

192

tooluniverse-target-research

mims-harvard

Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.

52

You might also like

flutter-development

aj-geddes

Build beautiful cross-platform mobile apps with Flutter and Dart. Covers widgets, state management with Provider/BLoC, navigation, API integration, and material design.

1,4071,302

drawio-diagrams-enhanced

jgtolentino

Create professional draw.io (diagrams.net) diagrams in XML format (.drawio files) with integrated PMP/PMBOK methodologies, extensive visual asset libraries, and industry-standard professional templates. Use this skill when users ask to create flowcharts, swimlane diagrams, cross-functional flowcharts, org charts, network diagrams, UML diagrams, BPMN, project management diagrams (WBS, Gantt, PERT, RACI), risk matrices, stakeholder maps, or any other visual diagram in draw.io format. This skill includes access to custom shape libraries for icons, clipart, and professional symbols.

1,2201,024

ui-ux-pro-max

nextlevelbuilder

"UI/UX design intelligence. 50 styles, 21 palettes, 50 font pairings, 20 charts, 8 stacks (React, Next.js, Vue, Svelte, SwiftUI, React Native, Flutter, Tailwind). Actions: plan, build, create, design, implement, review, fix, improve, optimize, enhance, refactor, check UI/UX code. Projects: website, landing page, dashboard, admin panel, e-commerce, SaaS, portfolio, blog, mobile app, .html, .tsx, .vue, .svelte. Elements: button, modal, navbar, sidebar, card, table, form, chart. Styles: glassmorphism, claymorphism, minimalism, brutalism, neumorphism, bento grid, dark mode, responsive, skeuomorphism, flat design. Topics: color palette, accessibility, animation, layout, typography, font pairing, spacing, hover, shadow, gradient."

9001,013

godot

bfollington

This skill should be used when working on Godot Engine projects. It provides specialized knowledge of Godot's file formats (.gd, .tscn, .tres), architecture patterns (component-based, signal-driven, resource-based), common pitfalls, validation tools, code templates, and CLI workflows. The `godot` command is available for running the game, validating scripts, importing resources, and exporting builds. Use this skill for tasks involving Godot game development, debugging scene/resource files, implementing game systems, or creating new Godot components.

958658

nano-banana-pro

garg-aayush

Generate and edit images using Google's Nano Banana Pro (Gemini 3 Pro Image) API. Use when the user asks to generate, create, edit, modify, change, alter, or update images. Also use when user references an existing image file and asks to modify it in any way (e.g., "modify this image", "change the background", "replace X with Y"). Supports both text-to-image generation and image-to-image editing with configurable resolution (1K default, 2K, or 4K for high resolution). DO NOT read the image file first - use this skill directly with the --input-image parameter.

970608

pdf-to-markdown

aliceisjustplaying

Convert entire PDF documents to clean, structured Markdown for full context loading. Use this skill when the user wants to extract ALL text from a PDF into context (not grep/search), when discussing or analyzing PDF content in full, when the user mentions "load the whole PDF", "bring the PDF into context", "read the entire PDF", or when partial extraction/grepping would miss important context. This is the preferred method for PDF text extraction over page-by-page or grep approaches.

1,033496

Stay ahead of the MCP ecosystem

Get weekly updates on new skills and servers.